Document is current
Any future updates will be listed below
-
Authors
Völkel, Cosima
De Wispelaere, Noémi
Weidemann, Sören
Gorbokon, Natalia
Lennartz, Maximilian
Luebke, Andreas M.
Hube-Magg, Claudia
Kluth, Martina
Fraune, Christoph
Möller, Katharina
Bernreuther, Christian
Lebok, Patrick
Clauditz, Till S.
Jacobsen, Frank
Sauter, Guido
Uhlig, Ria
Wilczak, Waldemar
Steurer, Stefan
Minner, Sarah
Krech, Rainer H.
Dum, David
Krech, Till
Marx, Andreas H.
Simon, Ronald https://orcid.org/0000-0003-0158-4258
Burandt, Eike
Menz, Anne
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 21 June 2021
Revised: 8 September 2021
Accepted: 10 September 2021
First Online: 24 September 2021
Change Date: 23 February 2022
Change Type: Update
Change Details: The Funding information has been added.
Declarations
: The usage of archived diagnostic left-over tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, §12,1) and by the local ethics committee (Ethics Commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki declaration.
: The CK5 antibody clone MSVA-605 M and the CK6 antibody clone MSVA-606R were provided from MS Validated Antibodies GmbH (owned by a family member of GS).
